Back
BCB Bancorp, Inc. Vs. Summit Therapeutics, Inc. Industry Stock Comparison
Sell
49
BCBP
BCB Bancorp, Inc.
Last Price:
$9.01
Seasonality Move:
-4.11%
Sell
46
SMMT
Summit Therapeutics, Inc.
Last Price:
$19.39
Seasonality Move:
3.83%
Sell
49
BCB Bancorp, Inc. (BCBP)
is a Sell
Is BCB Bancorp, Inc. a Buy, Sell or Hold?
-
The current BCB Bancorp, Inc. [BCBP] share price is $9.02. The Score for BCBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
BCBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Summit Therapeutics, Inc. [SMMT] share price is $19.38. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCBP Stock Price Chart
What is BCB Bancorp, Inc.'s stock price today?
-
The BCB Bancorp, Inc. share price today is $9.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCBP is experiencing slight selling pressure.
SMMT Stock Price Chart
What is Summit Therapeutics, Inc.'s stock price today?
-
The Summit Therapeutics, Inc. share price today is $19.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
BCBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 68.08 | Buy |
| Chaikin Money Flow: | -3677 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.05 - 8.73) | Buy |
| Bollinger Bands (100): | (7.81 - 8.47) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 68.51 | Buy |
| Chaikin Money Flow: | 1082070 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.14 - 17.58) | Buy |
| Bollinger Bands (100): | (15.48 - 18.14) | Buy |
BCBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.84 | Buy |
| 20-day SMA: | 8.44 | Buy |
| 50-day SMA: | 8.27 | Buy |
| 200-day SMA: | 8.32 | Buy |
| 8-day EMA: | 8.83 | Buy |
| 20-day EMA: | 8.57 | Buy |
| 50-day EMA: | 8.36 | Buy |
| 200-day EMA: | 8.52 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.7 | Buy |
| 20-day SMA: | 16.54 | Buy |
| 50-day SMA: | 15.9 | Buy |
| 200-day SMA: | 19.84 | Sell |
| 8-day EMA: | 17.92 | Buy |
| 20-day EMA: | 16.94 | Buy |
| 50-day EMA: | 16.55 | Buy |
| 200-day EMA: | 18.32 | Buy |
BCB Bancorp, Inc. Earnings Growth & BCBP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $1.61 per share, and an increase next year of $0.32 per share.
Summit Therapeutics, Inc. Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.
BCB Bancorp, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||